Download Files:
477 CAD – 4,304 CADPrice range: 477 CAD through 4,304 CAD
Products Details
Product Description
– Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia. Frovocimab is used to study hypercholesterolemia.
Web ID
– T77014
Storage Temperature
– -20℃
Shipping
– Blue Ice
CAS Number
– 1643672-70-1
Compound Purity
– 97.4% (SDS-PAGE); 95.3% (SEC-HPLC)
Pathway
– Others
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock